Bone remodeling disease
MONDO:0000833A bone disease that results in formation or resorption abnormalities located in bone.
413 clinical trials for this condition and its sub-types, 5 tagged with Bone remodeling disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Bone remodeling disease
-
Bone resorption disease 24 trials · 321 incl. sub-types
3 sub-types
- Osteoporosis 278 trials · 296 incl. sub-types Sub-types →
- Lytic metastatic bone lesion 2 trials
- Osteitis fibrosa 0 trials
-
Rickets 10 trials · 41 incl. sub-types
4 sub-types
- Hypophosphatemic rickets 3 trials · 19 incl. sub-types Sub-types →
- Renal osteodystrophy 12 trials
- Hypocalcemic rickets 0 trials · 3 incl. sub-types Sub-types →
- Vitamin D-dependent rickets 0 trials · 3 incl. sub-types Sub-types →
-
Hyperostosis 2 trials · 26 incl. sub-types
9 sub-types
- Exostosis 2 trials · 16 incl. sub-types Sub-types →
- Sclerosteosis 6 trials Sub-types →
- Bone Paget disease 2 trials Sub-types →
- Caffey disease 0 trials
- X-linked calvarial hyperostosis 0 trials
- Autosomal dominant osteosclerosis, Worth type 0 trials
- Craniodiaphyseal dysplasia 0 trials
- Diffuse idiopathic skeletal hyperostosis 0 trials
- Hyperostosis corticalis generalisata 0 trials
-
Osteosclerosis 1 trial · 16 incl. sub-types
3 sub-types
- Familial osteosclerosis 0 trials · 16 incl. sub-types Sub-types →
- Dysostosis, Stanescu type 0 trials
- Osteopoikilosis 0 trials Sub-types →
-
Fibrous dysplasia 11 trials
3 sub-types
- Polyostotic fibrous dysplasia 8 trials
- Monostotic fibrous dysplasia 0 trials
- Panostotic fibrous dysplasia 0 trials
-
Osteomalacia 2 trials · 4 incl. sub-types
1 sub-type
- Oncogenic osteomalacia 3 trials
Most studied deeper sub-types
-
A common supplement may shield bones in kidney disease — a trial puts it to the test
Disease control Stopped earlyThis pilot trial investigates whether potassium citrate can improve bone quality and strength in adults and children with chronic kidney disease. Participants take either potassium citrate or a placebo for six months, along with blood and urine tests and advanced bone scans. The …
Phase 2/3 • Sponsor: Albert Einstein College of Medicine • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Could a common cholesterol drug protect bones and hearts after spinal injury?
Disease control Stopped earlyThis study tested whether the statin drug rosuvastatin, taken daily with supplements, could improve bone density and reduce heart disease risk in adults with long-term spinal cord injury. Only 8 people enrolled before the trial was stopped early. Participants received either rosu…
Phase 2 • Sponsor: Dr. B. Catharine. Craven • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Elderly arthritis study reveals hidden health risks
Knowledge-focused Stopped earlyThis study aimed to understand how age influences serious health issues like infections, cancer, heart disease, and bone fractures in people with rheumatoid arthritis. Researchers compared patients over 65 with younger adults (18-50) who had the same disease. The study was stoppe…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
HIV drugs may weaken bones: new study investigates
Knowledge-focused Stopped earlyThis study looked at bone density in HIV-positive men to see if antiretroviral drugs cause bone thinning. Researchers compared men starting HIV treatment with those not yet on therapy over two years. The goal was to understand why bone loss is more common in HIV patients.
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC